136411-21-7 Usage
General Description
5-bromo-4-trifluoromethyl-thiazole-2-ylamine is a chemical compound with the molecular formula C5H3BrF3N3S. It is a thiazole derivative that contains a bromine atom, a trifluoromethyl group, and an amine functional group. 5-bromo-4-trifluoromethyl-thiazole-2-ylamine has potential applications in pharmaceutical and agrochemical industries due to its diverse biological activities. Specifically, it has been studied for its potential as a building block in the synthesis of various pharmaceutical drugs and agrochemical compounds. Additionally, it may have applications in medicinal chemistry, such as in the development of new treatments for various diseases. Its unique structure and properties make it a valuable molecule for further research and development in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 136411-21-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,4,1 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 136411-21:
(8*1)+(7*3)+(6*6)+(5*4)+(4*1)+(3*1)+(2*2)+(1*1)=97
97 % 10 = 7
So 136411-21-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H2BrF3N2S/c5-2-1(4(6,7)8)10-3(9)11-2/h(H2,9,10)
136411-21-7Relevant articles and documents
2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS
-
Paragraph 00162; 00405, (2021/06/26)
2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).
ARYL SULFONES AND USES RELATED THERETO
-
Page/Page column 92-93, (2010/02/14)
Aryl sulfone compounds of formula (I) and (II) are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders.